Bionovo Announces First Quarter 2009 Highlights and Financi...((A Development Stage Company) ...),Health

Date:5/7/2009

(A Development Stage Company) Condensed Consolidated Balance Sheets (in thousands, except share amounts) March 31, December 31, 2009 2008 (unaudited) ASSETS Current assets: Cash and cash equivalents $5,338 $3,270 Short-term investments 3,757 10,292 Receivables 67 126 Prepaid expenses and other current assets 438 805 Total current assets 9,600 14,493 Property and equipment, net 6,758 6,938 Other assets and patent pending, net 1,309 1,073 Total assets $17,667 $22,504 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Accounts payable $471 $521 Accrued clinical and costs of other studies 86 73 Accrued compensation and benefits 360 456 Current portion of lease obligations 656 682 Other current liabilities 570 595 Total current liabilities 2,143 2,327 Non-current portion of lease obligation 392 545 Commitments and contingencies Shareholders' equity: Preferred stock, $0.0001 par value; 10,000,000 shares authorized; none issued and outstanding - - Common stock $0.0001 p
'/>"/>

SOURCE Bionovo, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6
Related medicine technology :

1. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
2. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
3. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
4. Bionovos VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
5. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
6. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
7. Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta
8. Bionovos Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation
9. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
10. Bionovo Announces Publication of the Paper Detailing the Mechanism of Action of Its Cancer Drug BZL101
11. Bionovo Announces Positive Developments in On-going Phase 1/2 Cancer Drug Trial